SAN DIEGO, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Boundless Bio (Nasdaq: BOLD), a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to ...
Prior to the pandemic, Kerry Hilton and Francesco Lucarelli, then two of the leaders of HCB Health, sat down for breakfast at the Omni in downtown Austin. Over the course of the next few hours, they ...
Boundless Bio, a clinical-stage oncology company, announced its financial results for the first quarter of 2025, highlighting its ongoing commitments to developing innovative therapies for patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results